A share price of Jade Biosciences Inc [JBIO] is currently trading at $14.7, saw in change for the day. An important factor to consider is whether the stock is rising or falling in short-term value. The JBIO shares have gain 8.65% over the last week, with a monthly amount drifted -8.35%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Jade Biosciences Inc [NASDAQ: JBIO] stock has seen the most recent analyst activity on January 07, 2026, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $25. Previously, BTIG Research started tracking the stock with Buy rating on October 09, 2025, and set its price target to $28. On July 14, 2025, Jefferies initiated with a Buy rating and assigned a price target of $16 on the stock. Guggenheim upgraded its rating to a Buy but stick to its price target of $14 on June 16, 2025. Wedbush initiated its recommendation with a Outperform and recommended $17 as its price target on May 07, 2025. Stifel started tracking with a Buy rating for this stock on May 05, 2025, and assigned it a price target of $19. In a note dated May 02, 2025, TD Cowen initiated an Buy rating and provided a target price of $10 on this stock.
Jade Biosciences Inc experienced fluctuations in its stock price throughout the past year between $6.57 and $17.71. Currently, Wall Street analysts expect the stock to reach $26.5 within the next 12 months. Jade Biosciences Inc [NASDAQ: JBIO] shares were valued at $14.7 at the most recent close of the market. An investor can expect a potential return of 80.27% based on the average JBIO price forecast.
Analyzing the JBIO fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.49 and Total Capital is -0.36. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Jade Biosciences Inc [NASDAQ:JBIO] is 9.01. On the other hand, the Quick Ratio is 9.01, and the Cash Ratio is 2.24.
Transactions by insiders
Recent insider trading involved Atlas Venture Fund XII, L.P., Shareholder, that happened on Jun 25 ’25 when 28977.0 shares were purchased. Shareholder, Atlas Venture Associates XII, completed a deal on Jun 25 ’25 to buy 235.0 shares. Meanwhile, Shareholder Atlas Venture Fund XII, L.P. bought 16132.0 shares on Jun 24 ’25.
